Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 48 of 48 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
|
Company BD Technologies and Innovation (RTP) | Activity: Research and Development | Company Description BD is a global medical technology company working to improve medical discovery, diagnostics and the delivery of care. The RTP site, established in 1972, is the North American hub of BD's global enterprise R&D network. | Location Research Triangle Park |
 |
Company Allucent (Cary) | Activity: Contract Research and Testing | Company Description Allucent provides contract research services, including preclinical and clinical study design and management, regulatory assessments, data management and statistics, CMC program management, medical writing and submission of regulatory documents. | Location Cary |
| |
Company ALP Life Sciences Inc. | Activity: Research and Development | Company Description ALP Life Sciences has formulated and markets a High-3 fish oil supplement to increase omega-3 absorption and bioavailability for the treatment of fatty liver disease and inflammatory diseases. | Location Black Mountain |
| |
Company Altis BioSystems Inc. | Activity: Research and Development | Company Description Altis Biosystems has developed a patented stem cell platform that recreates the human intestinal epithelium, in a high-throughput format, for compound screening and microbiome research for biopharmaceutical companies. | Location Durham |
| |
Company Artiam Bio Inc. | Activity: Research and Development | Company Description Artiam Bio is targeting the endocannabinoid system to treat diseases using pharmacology and medicinal chemistry approaches. Artiam Bio is initially focused on non-alcoholic and alcoholic liver diseases, Prader Willi syndrome and cannabis use disorder. | Location Morrisville |
| |
Company Asensus Surgical Inc. | Activity: Research and Development | Company Description Asensus Surgical develops and sells instruments and robotics for laparoscopic minimally invasive surgery. | Location Durham |
| |
Company Beam Therapeutics | Activity: Production and Manufacturing | Company Description Beam Therapeutics will manufacture precision genetic medicines through the use of base editing technology at its RTP site. | Location Durham |
| |
Company Brightseed (Durham) | Activity: Research and Development | Company Description Brightseed developed an AI-driven discovery platform, Forager, to identify plant bioactives as potential therapeutic solutions. | Location Durham |
| |
Company CMP Pharma Inc. | Activity: Production and Manufacturing | Company Description CMP develops, manufactures and commercializes niche oral liquid medications that address the needs of patients with difficulty swallowing solid dosage forms. | Location Farmville |
| |
Company Cook Medical | Activity: Production and Manufacturing | Company Description Cook Medical develops and manufactures devices used in gastrointestinal endoscopy to diagnose and treat esophageal, gastric, pancreatic, biliary and colonic disorders. | Location Winston-Salem |
| |
Company Coprata Inc. | Activity: Research and Development | Company Description Coprata develops non-invasive physiological sampling technologies to detect or manage acute and chronic gastrointestinal diseases, provide early warning of infectious disease and monitor personalized wellness. | Location Durham |
| |
Company CRISPR Biotechnologies | Activity: Research and Development | Company Description CRISPR Biotech uses the novel CRISPR technologies in the microbiome to remedy disorders related to gut health. | Location Raleigh |
| |
Company Deep Blue Medical Advances Inc. | Activity: Research and Development | Company Description Deep Blue Medical Advances develops a surgical mesh for hernia repair and other medical device technologies from Duke University. | Location Durham |
| |
Company DILIsym Services Inc., a Simulations Plus company | Activity: Contract Research and Testing | Company Description DILIsym Services provides consulting services and proprietary software to the pharmaceutical and biotech industries to develop safer and more effective drug therapies. | Location Research Triangle Park |
| |
Company Gemelli Biotech | Activity: Sales and Operations | Company Description Gemelli Biotech develops diagnostics and therapeutics for microbiome diseases. | Location Raleigh |
| |
Company Ideal Health Biotechnology LLC | Activity: Research and Development | Company Description Ideal Health Biotechnology researches and develops dietary supplements made from plant-based compounds, including products derived from grape seed extract and algae for digestion, eye disease and diabetes. | Location Kannapolis |
| |
Company Lamassu Pharma Inc. | Activity: Research and Development | Company Description Lamassu Pharma is developing small molecule therapeutics to treat acute pancreatitis. | Location Durham |
| |
Company Ovesco Endoscopy USA Inc. (Cary) | Activity: Production and Manufacturing | Company Description Ovesco Endoscopy develops, manufactures and markets instruments and systems for the treatment of gastrointestinal diseases. | Location Cary |
| |
Company Panafina LLC | Activity: Research and Development | Company Description Panafina is developing a product for acute severe pancreatitis. | Location Morrisville |
| |
Company Postbiotics Inc. | Activity: Research and Development | Company Description Postbiotics is commercializing a probiotic strain (Lactobacillus paracasei) as a possible prevention against diseases caused by aging-related inflammation. | Location Winston-Salem |
| |
Company RedHill Biopharma Inc. | Activity: Sales and Operations | Company Description RedHill Biopharma develops and commercializes orally-administered, small-molecule drugs for the treatment of gastrointestinal and inflammatory diseases, including cancer. Its Raleigh site is the company's U.S. commercial headquarters. | Location Raleigh |
| |
Company SoyMeds Inc. | Activity: Research and Development | Company Description SoyMeds uses soybeans as a host to develop protein-based targets that can be used to diagnose and treat disease. SoyMeds' lead candidates include thyroglobulin and autoimmune (MS and MG) antigens. | Location Charlotte |
| |
Company T3D Therapeutics Inc. | Activity: Research and Development | Company Description T3D Therapeutics is developing a disease-modifying drug therapy for Alzheimer’s disease that may improve multiple disease defects. T3D is also targeting treatments for other neurodegenerative diseases including Huntington's Disease. | Location Research Triangle Park |
| |
Company UCB Biosciences Inc. | Activity: Research and Development | Company Description UCB Biosciences develops therapeutics for the treatment of severe, life-threatening neurological and inflammatory diseases, including epilepsy, Parkinson's disease, rheumatoid arthritis, Crohn's disease, psoriatic arthritis, lupus and osteoporosis. | Location Morrisville |